Literature DB >> 11490091

Effects-of fluoxetine on sensorimotor and spatial learning deficits following focal cerebral ischemia in rats.

Jukka Jolkkonen1, Kirsi Puurunen, Sanna Rantakömi, Jouni Sirviö, Antti Haapalinna, Juhani Sivenius.   

Abstract

Purpose: The present study investigated the effects of fluoxetine, a serotonin reuptake blocker, on behavioral deficits of rats subjected to transient focal cerebral ischemia.
Methods: The right middle cerebral artery of rats was occluded for 120 min using the intraluminal filament method. Fluoxetine treatment (5 mg/kg, i.p.) was started 2 days after ischemia induction and treatment was continued for 10 days thereafter. Sensorimotor recovery was assessed using the limb-placing test and cognitive impairment was assessed using a water-maze test at the end of the experiment.
Results: Fluoxetine treatment did not improve performance of ischemic rats in the limb-placing test. Nor was the ischemia-induced deficit in the water-maze test affected by fluoxetine. The infarct volumes in the cortex or striatum, determined after the experiment, were not different between ischemic groups.
Conclusion: These results suggest that subchronic fluoxetine treatment following experimental focal cerebral ischemia is not detrimental to behavioral outcome, but it also does not enhance spontaneous sensorimotor recovery or attenuate spatial learning deficits.

Entities:  

Year:  2000        PMID: 11490091

Source DB:  PubMed          Journal:  Restor Neurol Neurosci        ISSN: 0922-6028            Impact factor:   2.406


  7 in total

1.  Fluoxetine Enhances Neurogenesis in Aged Rats with Cortical Infarcts, but This is not Reflected in a Behavioral Recovery.

Authors:  Xiaoyu Sun; Zhike Zhou; Tingting Liu; Mei Zhao; Shanshan Zhao; Ting Xiao; Jukka Jolkkonen; Chuansheng Zhao
Journal:  J Mol Neurosci       Date:  2015-10-16       Impact factor: 3.444

2.  Effects of Fluoxetine on Hippocampal Neurogenesis and Neuroprotection in the Model of Global Cerebral Ischemia in Rats.

Authors:  Marina Khodanovich; Alena Kisel; Marina Kudabaeva; Galina Chernysheva; Vera Smolyakova; Elena Krutenkova; Irina Wasserlauf; Mark Plotnikov; Vasily Yarnykh
Journal:  Int J Mol Sci       Date:  2018-01-05       Impact factor: 5.923

Review 3.  Pharmacological Enhancement of Stroke Recovery.

Authors:  Amit Kumar; Tomoko Kitago
Journal:  Curr Neurol Neurosci Rep       Date:  2019-05-30       Impact factor: 5.081

4.  So you think you can jump? A novel long jump assessment to detect deficits in stroked mice.

Authors:  Nitish Mittal; Jie Pan; Julie Palmateer; Lianna Martin; Arushi Pandya; Sungita Kumar; Adaora Ofomata; Patricia D Hurn; Timothy Schallert
Journal:  J Neurosci Methods       Date:  2015-09-11       Impact factor: 2.390

Review 5.  Translational Hurdles in Stroke Recovery Studies.

Authors:  Jukka Jolkkonen; Gert Kwakkel
Journal:  Transl Stroke Res       Date:  2016-03-22       Impact factor: 6.829

6.  Bepridil decreases Aβ and calcium levels in the thalamus after middle cerebral artery occlusion in rats.

Authors:  Timo Sarajärvi; Anu Lipsanen; Petra Mäkinen; Sirpa Peräniemi; Hilkka Soininen; Annakaisa Haapasalo; Jukka Jolkkonen; Mikko Hiltunen
Journal:  J Cell Mol Med       Date:  2012-11       Impact factor: 5.310

7.  Alterations of the Ceramide Metabolism in the Peri-Infarct Cortex Are Independent of the Sphingomyelinase Pathway and Not Influenced by the Acid Sphingomyelinase Inhibitor Fluoxetine.

Authors:  R Brunkhorst; F Friedlaender; N Ferreirós; S Schwalm; A Koch; G Grammatikos; S Toennes; C Foerch; J Pfeilschifter; W Pfeilschifter
Journal:  Neural Plast       Date:  2015-10-28       Impact factor: 3.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.